News Releases News Releases IR Sub Menu - News & Events News ReleasesEvents & Presentations News Releases Year None2023202220212020201920182017201620152014 Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process April 7, 2023 Pear Therapeutics Announces Process Exploring Strategic Alternatives March 17, 2023 Pear Therapeutics to Participate in 43rd Annual Cowen Healthcare Conference February 27, 2023 Pear Therapeutics to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference February 2, 2023 Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders January 26, 2023 Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List January 18, 2023 Pear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series January 17, 2023 California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program January 12, 2023 Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics January 10, 2023 Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States January 4, 2023
News Releases Year None2023202220212020201920182017201620152014 Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process April 7, 2023 Pear Therapeutics Announces Process Exploring Strategic Alternatives March 17, 2023 Pear Therapeutics to Participate in 43rd Annual Cowen Healthcare Conference February 27, 2023 Pear Therapeutics to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference February 2, 2023 Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders January 26, 2023 Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List January 18, 2023 Pear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series January 17, 2023 California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program January 12, 2023 Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics January 10, 2023 Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States January 4, 2023